Back to Search Start Over

Tovorafenib Under Review for Relapsed or Progressive Pediatric Low-Grade Glioma

Authors :
Park, Brian
Source :
MPR Monthly Prescribing Reference. November 1, 2023
Publication Year :
2023

Abstract

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for tovorafenib for the treatment of relapsed or progressive pediatric low-grade glioma (pLGG). Tovorafenib [...]

Subjects

Subjects :
United States. Food and Drug Administration
Pediatrics
Gliomas -- Drug therapy
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.771027986

Tools

Authors Abstract Subjects Details